Cases & Deals

Abbott acquires Visiogen in a $400 million private company merger

Client(s) Abbott Laboratories

Jones Day advised Abbott Laboratories in the $400 million acquisition of Visiogen, Inc., an ophthalmic medical device company specializing in the development of new vision alternatives for patients with cataracts.

In addition to M&A representation, Jones Day provided antitrust, benefits, healthcare, and IP advice regarding this transaction.